Orchid Bioscience to leave instrument business. (Executive Briefing).
The company's products include SNPstream as well as SNP-IT primer extension technology and SNPware consumables for other vendors' hardware. The company has agreements with Affymetrix (see IBO 2/15/00 and 9/30/01), Amersham Biosciences (see IBO 8/15/00), PerkinElmer (see IBO 6/15/ 01) and Thermo Electron (see IBO 4/15/ 02), among others. The company forecasts revenues of $65 million for 2002.
|Printer friendly Cite/link Email Feedback|
|Publication:||Instrument Business Outlook|
|Article Type:||Brief Article|
|Date:||Oct 31, 2002|
|Previous Article:||Horiba's Jobin Yvon purchase Philips' business. (Executive Briefing).|
|Next Article:||The fall 2002 Business Climate Survey: stable sales expected.|